Real World Effectiveness Of Lixisenatide And Other Intensification Therapy In The Management Of Type 2 Diabetic Patients Uncontrolled With Basal Insulin

Trial Profile

Real World Effectiveness Of Lixisenatide And Other Intensification Therapy In The Management Of Type 2 Diabetic Patients Uncontrolled With Basal Insulin

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 14 Jun 2016

At a glance

  • Drugs Lixisenatide (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms INTENSE
  • Most Recent Events

    • 07 Nov 2014 Interim study results are expected in 2015, according to a Zealand Pharma media release.
    • 10 Jul 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top